|Videos|April 1, 2022

Clinical Trial Technology

Author(s)Almac

Almac provides an overview of their clinical technologies branch, their IRT offerings, and the current changes to the clinical development industry.

• Their key to success with their clients is creating configurable and customizable solutions.
• New guidance and regulations within the industry means adaptation.
• Almac has developed OVERSIGHT, a comprehensive tool to ensure clients have the full picture of their trial data.


Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.